BioSpace News Archive

Drug Development

Apellis Pharmaceuticals Announces First Patient Enrolled in Phase 3 APL-2 Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Soliris™

Apellis Pharmaceuticals Inc. announced that it has commenced its PEGASUS Phase 3 trial assessing the safety and efficacy of APL-2 in patients with paroxysmal nocturnal hemoglobinuria (PNH) compared to eculizumab (Soliris™).

July 5, 2018
·
6 min read
Pharm Country

NetworkNewsWire Announces Publication on Innovative Advancements in Med Tech Diagnostics

NetworkNewsWire announces the publication of an editorial featuring Zenosense

July 5, 2018
·
3 min read
Business

Florida Hospital Nicholson Center Earns American College of Surgeons AccreditationThe Nicholson Center becomes the second facility in the state of Florida to receive ACS-AEI designation

The Florida Hospital Nicholson Center, today announces it has earned the American College of Surgeons’ (ACS) status as a Focused Accredited Education Institute (AEI).

July 5, 2018
·
1 min read
Policy

IntelGenx Announces Notice of Grant of European Patent Covering Rizaport® VersaFilm™

IntelGenx Corp. announced that the European Patent Office (“EPO”) has issued a “Notice of Intention to Grant” for the Company’s European Patent Application Number 14832172.2 entitled, “Instantly Wettable Oral Film Dosage Form Without Surfactant or Polyalcohol.”

July 5, 2018
·
4 min read
Business

CHRISTUS Health Selects Trace to Improve Quality of Patient Registration EncountersHealth system will record and score face-to-face encounters with patients for quality improvement

Vyne Medical announced an agreement with CHRISTUS Health for implementation of its Trace voice recording and quality assurance platform.

July 5, 2018
·
2 min read